Cargando…
Systemic Administration of α7-Nicotinic Acetylcholine Receptor Ligands Does Not Improve Renal Injury or Behavior in Mice With Advanced Systemic Lupus Erythematosus
There is a critical need for safe treatment options to control inflammation in patients with systemic lupus erythematosus (SLE) since the inflammation contributes to morbidity and mortality in advanced disease. Endogenous neuroimmune mechanisms like the cholinergic anti-inflammatory pathway can be t...
Autores principales: | Morales, Jessica Y., Young-Stubbs, Cassandra M., Shimoura, Caroline G., Kem, William R., Uteshev, Victor V., Mathis, Keisa W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076522/ https://www.ncbi.nlm.nih.gov/pubmed/33928103 http://dx.doi.org/10.3389/fmed.2021.642960 |
Ejemplares similares
-
Cholinergic agonists reduce blood pressure in a mouse model of systemic lupus erythematosus
por: Fairley, Amber S., et al.
Publicado: (2017) -
Lipopolysaccharide Challenge Reveals Hypothalamic-Pituitary-Adrenal Axis Dysfunction in Murine Systemic Lupus Erythematosus
por: Pham, Grace S., et al.
Publicado: (2018) -
Editorial: Renal injury and the brain
por: Shimoura, Caroline G., et al.
Publicado: (2023) -
Should Renal Inflammation Be Targeted While Treating Hypertension?
por: Chaudhari, Sarika, et al.
Publicado: (2022) -
Somatic Integration of Single Ion Channel Responses of α7 Nicotinic Acetylcholine Receptors Enhanced by PNU-120596
por: Uteshev, Victor V.
Publicado: (2012)